1. Antiandrogen therapies for nonmetastatic castration-resistant prostate cancer: effectiveness and value : final evidence report Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, October 4, 2018 Subject(s): Androgen Antagonists -- therapeutic useProstatic Neoplasms -- drug therapyAndrogen Antagonists -- adverse effectsCost-Benefit AnalysisDisease ProgressionRandomized Controlled Trials as TopicTreatment OutcomeHumansUnited States
2. Advanced prostate cancer: developing gonadotropin-releasing hormone analogues Publication: Silver Spring, MD : Center for Drug Evaluation and Research, May 2022 Subject(s): Drug Development -- legislation & jurisprudenceGonadotropin-Releasing HormoneProstatic Neoplasms -- drug therapyUnited StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration
